Drug Development Team

The Drug Development Team at Exelixis is responsible for advancing novel cancer therapies from early-stage discovery through late-stage clinical development. This multidisciplinary team collaborates across various scientific domains including medicinal chemistry, biologics, clinical research, and regulatory affairs, to ensure the rigorous development of innovative treatments that can improve patient outcomes. They work meticulously to translate scientific discoveries into effective and safe cancer medicines, aiming to deliver new hope to patients battling cancer.